Conavi Medical Corp. (CNVI)
Market Closed
12 Dec, 20:00
TSX-V TSX-V Primary 
XFRA CA$
0. 49
+0.01
+2.08%
CA$
35.4M Market Cap
- P/E Ratio
0% Div Yield
2,380 Volume
- Eps
CA$ 0.48
Previous Close Day Range
0.48 0.49
Year Range
0.35 0.83
Want to track CNVI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 4 days
Summary
CNVI closed Friday higher at CA$0.49, an increase of 2.08% from Thursday's close, completing a monthly decrease of -9.26% or CA$0.05. Over the past 12 months, CNVI stock lost -26.87%.
CNVI is not paying dividends to its shareholders.
The last earnings report, released on Nov 10, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.01%, based on the last three reports. The next scheduled earnings report is due on Dec 18, 2025.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on TSX-V (CAD).
Conavi Medical Corp. (CNVI) FAQ
What is the stock price today?
The current price is CA$0.49.
On which exchange is it traded?
Conavi Medical Corp. is listed on TSX-V.
What is its stock symbol?
The ticker symbol is CNVI.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, the market cap is 35.4M.
When is the next earnings date?
The next earnings report will release on Dec 18, 2025.
Has Conavi Medical Corp. ever had a stock split?
No, there has never been a stock split.
Conavi Medical Corp. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Thomas Looby CEO | TSX-V Exchange | - ISIN |
| Canada Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Conavi Medical Corp. is a pioneering company based in Toronto, Canada, dedicated to the advancement of imaging technologies for minimally invasive cardiovascular procedures. With a strong focus on innovation, Conavi Medical Corp. designs, manufactures, and markets state-of-the-art solutions intended to enhance the precision and safety of such interventions. Their commitment to improving patient outcomes and supporting healthcare professionals is evident through their development of groundbreaking imaging systems that combine various imaging modalities for comprehensive coronary artery analysis.
Products and Services
- Novasight Hybrid System - This revolutionary system represents a significant advancement in imaging technology for cardiovascular care. By integrating intravascular ultrasound (IVUS) with optical coherence tomography (OCT), the Novasight Hybrid System provides simultaneous and co-registered imaging capabilities. This dual-modality approach allows for a more detailed and accurate visualization of coronary arteries, facilitating better decision-making during common minimally invasive procedures. The system underscores Conavi Medical Corp.'s dedication to enhancing the quality of care for patients undergoing cardiovascular interventions.
Contact Information
Address: 293 Lesmill Road
Phone: -
Website: https://conavi.com
2025 © Marketlog. All Rights Reserved.
